This document summarizes a student's submission on the topic of recombinant DNA technology. It discusses various topics related to rDNA technology including DNA, genes, plasmids, how recombinant DNA is made using transformation and other methods, use of restriction enzymes and ligases, gene therapy applications, and recent advances in using gene therapy to treat brain cancer and developing breast cancer treatments. The submission provides an overview of the key concepts and techniques in recombinant DNA technology.
This is one of the major chapters for the examination NEET. A few questions are expected from this chapter and carry more weight as per the NEET syllabus.
Describe the application of DNA profiling in paternity tests and forensic investigations
Analyze DNA profiles to draw conclusions about paternity tests and forensic investigations.
As a microbiologist, these are 15 unique areas of Biotechnology you should be familiar with, especially at the master's level
Please Note: If you can't read any text, kindly download and view as ppt
Study of cloning vectors and recombinant dna technologySteffi Thomas
Study of cloning vectors, restriction endonuclease and DNA ligase, Recombinant DNA technology, Application of genetic engineering in medicine, Application of rDNA technology and genetic engineering in the production of interferons, Vaccines-hepatitis-B, Hormones-Insulin, Brief introduction to PCR
A recombinant DNA molecule is produced by joining together two or more DNA segments usually originating from two different organisms.
More Specifically, a recombinant DNA molecule is a vector into which desired DNA fragment has been inserted to enable its cloning in an appropriate host.
Recombinant DNA molecules are produced with one of the following objectives:
1. To obtain large number of copies of specific DNA fragments.
2. Large scale production of the protein encoded by the gene.
3. Integration of the desired DNA fragment into target organism where it expresses itself.
Drought tolerant-genetically modified plants:
Present abiotic stress is a major challenge in our quest for sustainable food production as these may reduce the potential yields by 70% in crop plants
Of all abiotic stress, drought is regarded as the most damaging
Transgenic plants carrying genes for abiotic stress tolerance are being developed for water stress management
Conventional breeding approaches, involving inter specific and inter generic hybridizations and mutagenesis have been limited success.
Major problems have been the complexity of drought tolerance & low genetic yield components under drought conditions.
Unlike conventional plant breeding there is no need of repeated back crossing
Gene pyramiding or gene stacking through co-transformation of different genes with similar effects can be achieved.
This is one of the major chapters for the examination NEET. A few questions are expected from this chapter and carry more weight as per the NEET syllabus.
Describe the application of DNA profiling in paternity tests and forensic investigations
Analyze DNA profiles to draw conclusions about paternity tests and forensic investigations.
As a microbiologist, these are 15 unique areas of Biotechnology you should be familiar with, especially at the master's level
Please Note: If you can't read any text, kindly download and view as ppt
Study of cloning vectors and recombinant dna technologySteffi Thomas
Study of cloning vectors, restriction endonuclease and DNA ligase, Recombinant DNA technology, Application of genetic engineering in medicine, Application of rDNA technology and genetic engineering in the production of interferons, Vaccines-hepatitis-B, Hormones-Insulin, Brief introduction to PCR
A recombinant DNA molecule is produced by joining together two or more DNA segments usually originating from two different organisms.
More Specifically, a recombinant DNA molecule is a vector into which desired DNA fragment has been inserted to enable its cloning in an appropriate host.
Recombinant DNA molecules are produced with one of the following objectives:
1. To obtain large number of copies of specific DNA fragments.
2. Large scale production of the protein encoded by the gene.
3. Integration of the desired DNA fragment into target organism where it expresses itself.
Drought tolerant-genetically modified plants:
Present abiotic stress is a major challenge in our quest for sustainable food production as these may reduce the potential yields by 70% in crop plants
Of all abiotic stress, drought is regarded as the most damaging
Transgenic plants carrying genes for abiotic stress tolerance are being developed for water stress management
Conventional breeding approaches, involving inter specific and inter generic hybridizations and mutagenesis have been limited success.
Major problems have been the complexity of drought tolerance & low genetic yield components under drought conditions.
Unlike conventional plant breeding there is no need of repeated back crossing
Gene pyramiding or gene stacking through co-transformation of different genes with similar effects can be achieved.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. DEPARTMENT OF PHARMACEUTICAL SCIENCES,
KUMAUN UNIVERSITY
SUBMITTED BY:
SHWETA SINGH
M.PHARM 1ST YEAR
1
SUBMITTED TO:
Dr. Anita Singh
Senior Asst. Professor
TOPIC – RECOMBINANT DNA
TECHNOLOGY
2. Topics for Discussion
oBrief study of rDNA Technology
oHybridoma Technology
oGene Therapy
oClinical Application & Recent Advances in Gene Therapy
2
3. DNA
DNA is the keeper of the all information
needed to recreate an organism
Nucleotides are the building blocks of the
DNA
All DNA is made up of a base consisting
of sugar phosphates and nitrogen bases.
“Double helix"
The sugar used in DNA is deoxyribose.
DNA contain a anti-parallel strands.
DNA contains 4 nitrogen bases they are:
Purines: Adenine, Guanine
Pyrimidines: Thymine, Cytosine
They are found in pairs, A&T and G&C
3
4. GENE
A gene is a stretch of DNA that codes for a type of protein that has a
function in the organism.
It is a unit of heredity in a living organism. All living things depend on
genes.
Genes hold the information to build and maintain an organism’s cell
and pass genetics traits to off spring.
DNA does not actually make the organism, it only makes proteins.
The DNA is transcribed into mRNA and mRNA is translated into
protein, and the protein then forms the organism. (Central Dogma)
4
5. PLASMID
These are double stranded DNA that are usually circular and mostly
found inside certain bacterial specie e.g. E.coli.
However most plasmids are now commercially available, ready to be
used, providing specific fragment insertion sites.
Plasmids in genetic engineering are also known as ‘vectors’.
Vectors also include viruses known as bacterio‐phage that use
bacteria as their host to replicate.
Hence a bacterio‐phage can be used to transfect and create several
copies of the DNA fragment of interest by replicating several times in a
bacteria.
5
6. Recombinant DNA Technology
(rDNA)
Molecules of DNA from two different species that are inserted into a
host organism to produce new genetic combinations that are of value
to science, medicine, agriculture, and industry.
For example : DNA comprising an animal gene may be recombined
with DNA from a bacterium.
6
7. Recombinant DNA (rDNA)
7
DNA molecules constructed outside of living cells by
joining natural or synthetic DNA segments to DNA
molecules that can replicate in a living cell.
The DNA is inserted into another DNA molecule
called ‘vector’ .The recombinant vector is then
introduced into a host cell where it replicates itself,
the gene is then produced.
8. Basic Principles of rDNA Technology
Generation of DNA fragments & selection of the desired
piece of DNA.
Insertion of the selected DNA into a cloning vector to create
a rDNA or chimeric DNA.
Introduction of the recombinant vectors into host cells.
Multiplication & selection of clones containing the
recombinant molecules.
Expression of the gene to produce the desired product. 8
10. How is
Recombinant
DNA made?
There are three different methods
by which Recombinant DNA is
made:
Transformation
Phage Introduction
Non-Bacterial Transformation. 10
11. Transformation
Transformation is the process by which exogenous DNA is
transferred into the host cell. Transformation usually implies uptake
of DNA into bacterial, yeast or plant cells, while transfection is a term
usually reserved for mammalian cells.
The first step in transformation is to select a piece of DNA to be
inserted into a vector.
The second step is to cut that piece of DNA with a restriction
enzyme and then ligate the DNA insert into the vector with DNA
Ligase. The insert contains a selectable marker which allows for
identification of recombinant molecules. The vector is inserted into a
host cell, in a process called transformation.
One example of a possible host cell is E. coli. The host cells must be
specially prepared to take up the foreign DNA.
11
12. Phage Introduction
Phage introduction is the process of transfection, which is
also known as transformation, except a phage is used
instead of bacteria.
In vitro packaging of a vector is used. This uses lambda or
MI3 phages to produce phage plaques which contain
recombinants.
The recombinants that are created can be identified by
differences in the recombinants and non-recombinants using
various selection methods.
12
13. Non-Bacterial transformation
Microinjection, the DNA is injected directly into the
nucleus of the cell being transformed.
The host cells are bombarded with high velocity
micro-projectiles, such as particles of gold or
tungsten that have been coated with DNA.
13
14. Restriction Endonucleases
Enzymes for the manipulation of DNA.
Are bacterial enzymes that can cut/split DNA at specific
sites.
These were first discovered in E.coli restricting the
replication of bacteriophages,by cutting the viral DNA(The
host E.coli DNA is protected from cleavage by addition of
methyl groups).Thus,the enzymes that restrict the viral
replication are known as restriction enzymes or restriction
endonucleases.
14
16. DNA ligases
These were originally isolated from viruses, also occur in
E.coli & eukaryotic cells.
The cut DNA fragments are covalently joined together by
DNA ligases.
DNA ligase joins the DNA fragments by forming a
phosphodiester bond b/n the phosphate group of 5’-carbon
of one deoxyribose with the hydroxyl group of 3’-carbon of
another deoxyribose.
16
18. Steps involved in rDNA
Technology
1. Isolation of Genetic Material
The first step in rDNA technology is to isolate the desired
DNA in its pure form i.e. free from other macromolecules.
Since DNA exists within the cell membrane along with
other macromolecules such as RNA, polysaccharides,
proteins, and lipids, it must be separated and purified which
involves enzymes such as lysozymes, cellulase, chitinase,
ribonuclease, proteases etc.
Other macromolecules are removable with other enzymes
or treatments. Ultimately, the addition of ethanol causes the
DNA to precipitate out as fine threads. This is then spooled
out to give purified DNA
18
19. 2. Restriction Enzyme Digestion
Restriction enzymes act as molecular scissors that cut DNA
at specific locations. These reactions are called ‘restriction
enzyme digestions’.
They involve the incubation of the purified DNA with the
selected restriction enzyme, at conditions optimal for that
specific enzyme.
The technique ‘Agarose Gel Electrophoresis’ reveals the
progress of the restriction enzyme digestion.
This technique involves running out the DNA on an agarose
gel. On the application of current, the negatively charged
DNA travels to the positive electrode and is separated out
based on size. This allows separating and cutting out the
digested DNA fragments.
19
20. 3. Amplification Using PCR
Polymerase Chain Reaction or PCR is a method of
making multiple copies of a DNA sequence using the
enzyme – DNA polymerase in vitro.
It helps to amplify a single copy or a few copies of DNA
into thousands to millions of copies.
PCR reactions are run on ‘thermal cyclers’ using the
following components:
i. Template – DNA to be amplified
ii. Primers – small, chemically synthesized oligonucleotides
that are complementary to a region of the DNA.
iii. Enzyme – DNA polymerase
20
21. iv. Nucleotides – needed to extend the primers by the
enzyme.
The cut fragments of DNA can be amplified using PCR
and then ligated with the cut vector.
21
22. 4. Ligation of DNA Molecules
The purified DNA and the vector of interest are cut with the
same restriction enzyme.
This gives us the cut fragment of DNA and the cut vector,
that is now open.
The process of joining these two pieces together using the
enzyme ‘DNA ligase’ is ‘ligation’.
The resulting DNA molecule is a hybrid of two DNA
molecules – the interest molecule and the vector. In the ter-
minology of genetics this intermixing of different DNA strands
is called recombination.
22
23. Hence, this new hybrid DNA molecule is also called a
recombinant DNA molecule and the technology is referred to
as the recombinant DNA technology.
23
24. 5. Insertion of Recombinant DNA Into Host
In this step, the recombinant DNA is introduced into a
recipient host cell mostly, a bacterial cell. This process
is ‘Transformation’.
Bacterial cells do not accept foreign DNA easily. Therefore,
they are treated to make them ‘competent’ to accept new
DNA. The processes used may be thermal shock, Ca++ ion
treatment, electroporation etc.
24
25. 6. Isolation of Recombinant Cells
The transformation process generates a mixed population
of transformed and non-trans- formed host cells.
The selection process involves filtering the transformed
host cells only.
For isolation of recombinant cell from non-recombinant
cell, marker gene of plasmid vector is employed.
For examples, PBR322 plasmid vector contains different
marker gene (Ampicillin resistant gene and Tetracycline
resistant gene. When pst1 RE is used it knock out Ampicillin
resistant gene from the plasmid, so that the recombinant cell
become sensitive to Ampicillin.
25
26. Application of Recombinant DNA
technology
1. The most common application of recombinant DNA is in
basic research, in which the technology is important to
most current work in the biological and biomedical
sciences.
2. Recombinant DNA is used to identify, map and sequence
genes, and to determine their function.
3. Recombinant proteins are widely used as reagents in
laboratory experiments and to generate antibody probes
for examining protein synthesis within cells and
organisms.
26
27. 4. Many additional practical applications of recombinant
DNA are found in industry, food production, human and
veterinary medicine, agriculture, and bioengineering.
5. DNA technology is also used to detect the presence of
HIV in a person.
6. Application of recombinant DNA technology in
Agriculture – For example, manufacture of Bt-Cotton to
protect the plant against ball worms.
7. Application of medicines – Insulin production by DNA
recombinant technology is a classic example.
8. Gene Therapy – It is used as an attempt to correct the
gene defects which give rise to heredity diseases.
9. Clinical diagnosis – ELISA is an example where the
application of recombinant DNA is possible.
27
28. Hybridoma Technology
Hybridoma technology is a method for producing large
numbers of identical antibodies (also called monoclonal
antibodies).
This process starts by injecting a mouse (or other
mammal) with an antigen that provokes an immune
response. A type of white blood cell, the B cell, produces
antibodies that bind to the injected antigen.
These antibody producing B-cells are then harvested from
the mouse and, in turn, fusedwith immortal B cell cancer
cells, a myeloma to produce a hybrid cell line called
a hybridoma, which has both the antibody-producing ability
of the B-cell and the longevity and reproductivity of the
myeloma.
28
30. MONOCLONAL ANTIBODY
Monoclonal antibodies (mAb)
are antibodies that are identical
because they are produced by
one type of immune cell, all
clones of a single parent cell.
Basically produced by white
blood cell which is called as
plasma cell.
Is used for treatment of
cancerous cells and as anti-
venom ( anti snake venom)
30
31. PROCEDURE :
1. Immunization of specific animal which generate
hybridoma cell with spleen cell.
2. Isolation of myeloma cells.
3. Fusion between spleen cell and myeloma cell.
4. Selection of HAT medium.
5. Isolation of hybridoma cell.
6. Screening of hybridoma cell
31
32. 1. Immunization of specific animal
An antigen immunized to an animal (like mice) via
intravenously(directly to blood) by injection.
Where in spleen it activate B-cell which produce plasma cell
(spleen cell).
Plasma cell to produce monoclonal antibodies
Isolation of plasma cell from spleen of animal pecific
animal
32
33. 2. Isolation of myeloma cells.
Myeloma cells are cancerous cells which is isolated from
bone-marrow.
Myeloma cells are generally immortal in nature (that which
never dies) and has multiplication property.
3. Fusion of spleen cell and myeloma cell
It requires PEG (poly ethylene glycone) medium for fusion
It can also done by electro fusion.
Fusion between spleen cell and myeloma cell produced
five different types of cells.
1. Fused plasma 4. Fused myeloma
2. Hybridoma 5. Unfused plasma
3. Unfused myeloma
33
34. Application of Hybridoma Technology
Serological
Identification of ABO blood group
Diagnosis
• Detection of pregnancy by assaying of hormones with
monoclonal.
•Separation of one substance from a mixture of very similar
molecules.
34
35. Immunopurification
•Purification of individual interferon using monoclonal.
•Inactivation of T-lymphocytes responsible for rejection of
organ transplants.
Therapy
• Removal of tumor cell from bone marrow.
•Treatment of acute renal failure.
•Treatment malignant leukemic cells, B cell lymphomas, and
a variety of allograft rejections after transplantation.
35
36. Gene Therapy
Gene therapy is the insertion of genes into an individual's
cells and tissues to treat a disease, such as a hereditary
disease in which a deleterious mutant allele is replaced with
a functional one.
Although the technology is still in its infancy, it has been
used with some success.
Researchers are studying gene therapy for a number of
diseases, such as
1. Severe combined immuno-deficiencies (SCID)
2. Hemophilia 4. HIV
3. Parkinson's disease 5. Cancer
36
37. How it work ?
1. A vector delivers the therapeutic gene into a patient‟s
target cell
2. The target cells become infected with the viral vector
3. The vector‟s genetic material is inserted into the target
cell
4. Functional proteins are created from the therapeutic
gene causing the cell to return to a normal state
37
41. Clinical Application & Recent
Advances in Gene Therapy
First Real-Time MRI-Guided Gene Therapy for Brain
Cancer
Neurosurgeons at the University of California, San Diego
School of Medicine and UC San Diego Moores Cancer
Center are among the first in the world to utilize real-time
magnetic resonance imaging (MRI) guidance for delivery of
gene therapy as a potential treatment for brain tumors.
Using MRI navigational technology, neurosurgeons can
inject Toca 511 (vocimagene amiretrorepvec), a novel
investigational gene therapy, directly into a brain malignancy
41
42. The new approach offers a precise way to deliver a
therapeutic virus designed to make the tumor susceptible to
cancer-killing drugs
Toca 511 is a retrovirus engineered to selectively replicate
in cancer cells, such as glioblastomas.
Toca 511 produces an enzyme that converts an anti-fungal
drug, flucytosine (5-FC), into the anti-cancer drug 5-
fluorouracil (5-FU).
After the injection of Toca 511, the patients are treated with
an investigational extended- release oral formulation of 5-FC
called Toca FC.
Cancer cell killing takes place when 5-FC comes into
contact with cells infected with Toca 511.
42
43. UCLA researchers combine cellular and gene
therapies to develop treatment for breast cancer
Carol Kruse, a professor of neurosurgery and member of
the Jonson Cancer Center and the UCLA Brain Research
Institute led the research on breast cancer
Breast cancer is the most common form of cancer in
women, and metastasis is a major cause of health
deterioration and death from the disease
Cellular therapy and gene therapy were used together to
treat breast cancer
Cellular therapy is a type of immunotherapy that uses T
cells, the foot soldiers of the immune system, that have been
sensitized in the laboratory to kill breast cancer cells.
43
44. These sensitized T cells are injected into the parts of the
brain to which cancer has spread.
The research shows that the T cells can move through
tissue and recognize and directly kill the tumor cells
44
45. Mucopolysaccharidosis Type IIIA potential gene
therapy
Mucopolysaccharidosis Type IIIA (MPSIIIA) is a metabolic
disorder in which the body is missing an enzyme that is
required to break down long chains of sugars known as
glycosaminoglycans .
The glycosaminoglycans collect in the body and cause
damage, particularly in the brain if not broken.
Fàtima Bosch and colleagues at Universit at Autònoma de
Barcelona in Spain developed a form of gene therapy to
replace the enzyme that is missing in MPSIIIA
They injected the replacement gene into the cerebrospinal
fluid that surrounds the brain and spinal cord .
45
46. This study demonstrates that gene therapy can be delivered
to the brain through the cerebrospinal fluid and suggests that
this approach could potentially be used as a therapy for
MPSIIIA.
46
47. Referances
1. Verma, P. S., & Agrawal, V. K. (2006). Cell Biology, Genetics, Molecular Biology, Evolution & Ecology (1 ed.). S .Chand and
company Ltd.
2. Klug, W. S., & Cummings, M. R. (2003). Concepts of genetics. Upper Saddle River, N.J: Prentice Hall.
3. https://byjus.com/biology/recombinant-dna-technology/
4. https://en.wikipedia.org/wiki/Recombinant_DNA
5. https://www.britannica.com/science/recombinant-DNA-technology
6. https://www.quora.com/What-are-the-advantages-and-disadvantages-of-recombinant-DNA
47